6-chloro-N-(3,4-difluorophenyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)pyrimidin-4-amine;2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)-6-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-4-amine;(1R,4R)-2-methyl-2,5-diazabicyclo[2.2.1]heptane
C64H74ClF4N21 — CID 158017310
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-N-(3,4-difluorophenyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)pyrimidin-4-amine;2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)-6-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-4-amine;(1R,4R)-2-methyl-2,5-diazabicyclo[2.2.1]heptane
6-chloro-N-(3,4-difluorophenyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)pyrimidin-4-amine;2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)-6-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-4-amine;(1R,4R)-2-methyl-2,5-diazabicyclo[2.2.1]heptane (PubChem CID 158017310) has the molecular formula C64H74ClF4N21 and a molecular weight of 1248.89 g/mol. Its IUPAC name is 6-chloro-N-(3,4-difluorophenyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)pyrimidin-4-amine;2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)-6-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-4-amine;(1R,4R)-2-methyl-2,5-diazabicyclo[2.2.1]heptane.
Molecular Properties
| Compound Name | 6-chloro-N-(3,4-difluorophenyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)pyrimidin-4-amine;2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)-6-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-4-amine;(1R,4R)-2-methyl-2,5-diazabicyclo[2.2.1]heptane |
|---|---|
| PubChem CID | 158017310 |
| Molecular Formula | C64H74ClF4N21 |
| Molecular Weight | 1248.89 g/mol |
| Exact Mass | 1247.61 |
| IUPAC Name | 6-chloro-N-(3,4-difluorophenyl)-2-(3,5-dimethylpyrazol-1-yl)pyrimidin-4-amine;6-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)pyrimidin-4-amine;2-(3,5-dimethylpyrazol-1-yl)-N-(3-fluoro-4-methylphenyl)-6-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyrimidin-4-amine;(1R,4R)-2-methyl-2,5-diazabicyclo[2.2.1]heptane |
| SMILES | CN1C[C@H]2C[C@@H]1CN2.Cc1cc(C)n(-c2nc(Cl)cc(Nc3ccc(F)c(F)c3)n2)n1.Cc1cc(C)n(-c2nc(Nc3ccc(C)c(F)c3)cc(N3C[C@H]4C[C@@H]3CN4)n2)n1.Cc1cc(C)n(-c2nc(Nc3ccc(C)c(F)c3)cc(N3C[C@H]4C[C@@H]3CN4C)n2)n1 |
| InChI | InChI=1S/C22H26FN7.C21H24FN7.C15H12ClF2N5.C6H12N2/c1-13-5-6-16(8-19(13)23)24-20-10-21(29-12-17-9-18(29)11-28(17)4)26-22(25-20)30-15(3)7-14(2)27-30;1-12-4-5-15(8-18(12)22)24-19-9-20(28-11-16-7-17(28)10-23-16)26-21(25-19)29-14(3)6-13(2)27-29;1-8-5-9(2)23(22-8)15-20-13(16)7-14(21-15)19-10-3-4-11(17)12(18)6-10;1-8-4-5-2-6(8)3-7-5/h5-8,10,17-18H,9,11-12H2,1-4H3,(H,24,25,26);4-6,8-9,16-17,23H,7,10-11H2,1-3H3,(H,24,25,26);3-7H,1-2H3,(H,19,20,21);5-7H,2-4H2,1H3/t17-,18-;16-,17-;;5-,6-/m11.1/s1 |
| InChIKey | FFQAIYYBOOKDMX-KZXZKEMGSA-N |
| XLogP | 10.00 |
| TPSA | 203.91 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 90 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1248.89 |
| LogP ≤ 5 | 10.00 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158017310 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.